Schrodinger, Inc. Common Stock
$29.02
-$1.22 (-4.03%)
$28.55Day Range$30.22
Key Statistics
Market Cap
$2.17B
Shares Outstanding
74.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 6, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$29.32
Day High
$30.22
Day Low
$28.55
Volume
5.23M
VWAP
$29.17
Prev Close
$30.24
Transactions
--
Acc. Volume
--
About Schrodinger, Inc. Common Stock
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
PHARMACEUTICAL PREPARATIONSSIC 2834850 employees1540 BROADWAY, NEW YORK, NY, 10036503-299-1150IPO Feb 6, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001490978
- Composite FIGI
- BBG000T88BN2
- Share Class FIGI
- BBG001SZK2K0
- Ticker Root
- SDGR
- SIC Code
- 2834
About Schrodinger, Inc. Common Stock (SDGR) Stock
Schrodinger, Inc. Common Stock (SDGR) closed the 2026-09-18 session at $29.02, down 4.03% versus the previous close (-1.22). The stock opened at $29.32 and traded between $28.55 and $30.22 during that session. Session trading volume was 5.2M shares. The volume-weighted average price (VWAP) is $29.17.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Schrodinger, Inc. Common Stock has a market capitalization of $2.17 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SDGR is listed on the XNAS exchange. The company employs approximately 850 people. Schrodinger, Inc. Common Stock is headquartered in NEW YORK, NY. The recorded listing date is 2020-02-06.
On this page you can find market SDGR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.